NEW YORK (GenomeWeb) – Proteome Sciences said today it has conditionally raised £2.5 million ($3.9 million) through the placement of nearly 13.9 new ordinary shares of the company's stock. 

The shares were priced at 18 pence. Proteome Sciences will apply to place the shares for trading on the London Stock Exchanges' AIM on or around July 2, the company said. 

Proteome Sciences Executive Chairman Christopher Pearce has subscribed to about 1.8 million shares in the placement, while Vulpes Investment Management Private has subscribed to nearly 2.6 million shares. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.